Bio-Resonance Device for Extraction and Application of Special Therapeutic Frequencies

Abstract
A bio-resonance therapeutic device to extract and apply special therapeutic bio-
resonance frequencies. The device comprises of: frequency generator, isolation and
protection circuit, power source and storage and processing unit. The special
therapeutic bio-resonance frequencies are extracted from the dominant frequency
(with high power) of the Holy Quran verses recitation. Exposure time for each
frequency depending on its power spectral density (PSD), such that the exposure time
for the frequency with higher PSD is greater than the exposure time for the frequency
with lower PSD.

Technical Background:
Bio-resonance is based on the idea of using weak electromagnetic oscillations
(frequencies), innate to the human body. It is based on the fact that each tissue has a resonant
frequency and every cell in the human body resonates at a particular frequency. Under normal
physiological conditions, a human body has relative synchronization of different oscillatory
processes corresponding to each organ of the body. However, when pathological condition
arises, disturbances of oscillatory processes are observed. This could be expressed as a
disturbance of rhythms of basic physiological processes leading to disease. Therapy oscillations
in the form of electrical signals that have controlled voltages and currents are fed back
painlessly to the patient. These oscillations cause a therapeutic effect by negating or reducing
the unhealthy oscillations and by exciting or strengthening the normal healthy oscillations.
In general, the equipment used in bioresonance consists of therapeutic part and diagnostic
part. The diagnostic part is used to measure the oscillations that are produced by the body
while the therapeutic part is used to inject the oscillations (therapeutic frequencies) inside the
body using a pair of electrodes each of them is placed or hold by a hand.
It is to the knowledge of the authors of this document that in the previous available Bio-
resonance devices or electronic muscle stimulators there is no specific guidelines to
scientifically choose the right resonance frequency for each pathological condition. These
frequencies are usually chosen and used either based on the expertise of the bioresonance
practitioner, based on trial and error, or based on biofeedback system.

1
There are many systems that use biofeedback principle. Some of them are not in the context of
bioresonance feedback. Known instruments of this type provide indication of measurable
physiological activities such as heart rate, body temperature, blood pressure, brain wave, etc.
In the context of bioresonance biofeedback; the instrument measures body oscillations (or
some other physiological quantities) and then based on these measurements a certain
frequency or multi-frequency are chosen to be injected into the subject. Such application can
be seen in USSR Patent 1,481,920 issued November 1986 to Zaguskin et al. In which the cell
biorhythms are determined at the first step. Then the physical factor applied to the biological
object is modulated by at least three frequencies selected from a measured cell rhythm
spectrum. In European patent WO0024311(A1) (also published as US6261236), issued May
2000 to Grimblatov Valentin; a physical factor is applied to a for treatment purposes in
coordination of cycles of arterial blood pulse flow of a Patent EA960041(A1) (also published as
RU2070406) issued June 1997 to Gotovskij Yurij V, also provide a detailed description of a
system to measure the resonance frequencies and then apply the therapeutic frequencies.
Patent WO2007104471(A1) (also published as EP1993666) issued in September 2007 to
Zimmermann Uwe describes a bioresonance therapy appliance without any claims about
selecting the proper therapeutic frequency.
There are other products related to muscle stimulations such as EP0204525A1 dated December
1986 entitled low-frequency therapeutic device uses oscillator circuits to produce the
stimulating frequencies, a signal output circuit responsive to the music signal having amplitude
greater than a certain level for generating an output signal. They produce different frequencies
in response to the output signal generated based on the music signal amplitude only meaning
that it uses signal level in time domain not in frequency domain.
Patent WO0071075A dated November 2000 entitled body treatment product which provide a
body treatment product adapted to stimulate the muscles which avoids, at least to a significant
extent, the problems associated with the known devices and to provide a muscle stimulator
which allows the subject more easily to pursue other activities during its use than the case with
known devices. It claims the control of the electrical pulses parameters which are the duration
and the frequency using the control unit without any claims about the criteria of this control.
Patent WO2007081284A1 dated July 2007 entitled system and methods of electronic muscle
stimulation where the control signal of the muscle stimulator being dependent on the
predominant frequency signal extracted using the highest level of a bandpass filter.
The invention presented here is different in: the mapping of the power, the method of
obtaining the dominant (those who have high power compared to other frequencies in the
same Quranic verses recitation) frequency and the number of the predominant frequencies
from the Holly Quran recitation.

2
Future Work

More enhancements will be conducted on the porotype of the device to make more friendly
and more relaxing for the patient. This can be achieved by adding more features and options.
Such as, colored graphical LCDs and other controllers on the device to make the device easier
and attractive for both the therapist and the patient.
The future plans consist of manufacturing number of this device. Each device will have a group
of threptic frequency that will be assigned for certain diseases. The number of diseases that can
be treated with this device is endless since we are working on the frequency of the cells.

The fund is needed for the following categories:

1) Manufacturing of the device in mass production
2) Cost of Treating different patients using the device which includes different types of
medical tests like blood analysis and medical imaging and other tests.
3) Marketing of this device in Jordan and Gulf region as a beginning.
4) Other costs

Conclusion

This device is promising and will have high values for both the treating and helping peoples
specially with long term diseases and economical profits. This need a commitment from the
fund provider that meet with the commitment of the inventors to achieve these goals.